Lactation Stage Specific Infant Nutrition
Patent No. EP4346444 (titled "Lactation Stage Specific Infant Nutrition") was filed by Nutricia on Jun 2, 2022. The application was issued on Aug 27, 2025.
Patent Summary
An age-specific infant formula for infants aged 0 to 4 months is disclosed, designed to mimic human milk composition to support gut and immune system maturation. The formula comprises 0.05–0.30 g/l 3'-sialyllactose (3'-SL) (preferably 0.08–0.25 g/l, more preferably 0.10–0.20 g/l, and even more preferably 0.10–0.18 g/l), 0.3–1 g/l 3-fucosyllactose (3-FL) (preferably 0.4–0.9 g/l, more preferably 0.5–0.8 g/l), and difucosyllactose (DFL). The 3'-SL and DFL are present in a weight ratio between 1:1.1 and 1:2. The composition may further include 2'-fucosyllactose (2'-FL), fructo-oligosaccharides (average DP >20), and galacto-oligosaccharides (average DP 3–7). The formula may be provided in liquid or powder form and may be adapted for infants
Patent Family
Patent Oppositions (3)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP4346444
- Application Number
- EP22731255A
- Filing Date
- Jun 2, 2022
- Status
- Granted And Under Opposition
- Jul 25, 2025
- Publication Date
- Aug 27, 2025
- External Links
- Slate, Register , Google Patents